
Nasal spray trial for AstraZeneca’s COVID vaccine suffers setback
October 11, 2022
The COVID-19 shot, which Oxford University researchers and AstraZeneca Plc jointly developed, suffered a setback on Tuesday when first tests on humans did not yield the anticipated protection levels. In the trial, which was in the first of usually three








